Mesoblast Limited (ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today announced a significant achievement in its pivotal Phase 3 clinical trial. The ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L ...

This ASX biotech's shares are rising after hitting a key milestone. Here’s what the update means and what investors are ...

What kinds of shoes might be contributing to your back pain, and what kinds of shoes might help? Here’s what two podiatrists ...

Lower back pain is a common and often debilitating health hardship, affecting nearly 600 million people globally. Here's how ...

Mesoblast Ltd (ASX: MSB) hits a key Phase 3 trial recruitment target in chronic low back pain, advancing towards FDA approval ...

Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its ...

A young woman was diagnosed with ovarian cancer aged just 22 after her symptoms including a "pregnancy-like" lump were ...

Chiropractors are my kind of people.”RFK Jr. to ChiropractorsNot certain who was more insulted, although it appears both ...

If your back has been giving you trouble lately, you have plenty of company. Most of us deal with back pain at one time or ...

A urinary tract infection may begin as a mild irritation, but if ignored, it can silently climb to the kidneys, leading to ...

A man who suffered severe back and joint pain from the age of 15 was finally diagnosed with inflammatory arthritis 11 years later, after being wrongly told his pain was due to one leg being shorter ...